Katerina Antoniou, PhD

Assistant Professor of Pharmacology,

Department of Pharmacology, Medical School, University of Ioannina

Email: kantoniu@cc.uoi.gr

 

Research interests

 

1. Mechanisms underlying the psychostimulant properties of d-amphetamine, cocaine, caffeine and cannabinods. Individual differences and study of phenotypes following amphetamine, cocaine and cannabinoids administration.

2. Preclinical models of drug abuse, schizophrenia and stress/depression

3. Preclinical screening of novel substances with CNS properties

 

Publications

 

1.      K. Antoniou, A. Galanopoulos, S. Vlachou, T. Kourouli, V. Nahmias, K. Thermos, G. Panagis, Z. Daifoti, M. Marselos, D. PapahatjisandC. Spyraki. Behavioral pharmacological properties of a novel cannabinoid 1,1-dithiolane Δ8-ΤΗC analog, AMG-3. Behavioral Pharmacology 16: 499-510, 2005.

2.      Antoniou K, Papadopoulou-Daifoti Z, Hyphantis T, Papathanasiou G, Bekris E, Marselos M, Panlilio L, Muller CE, Goldberg SR, Ferre S.A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.Psychopharmacology (Berl).183(2):154-62, 2005.

3.      K. Antoniou, A. Galanopoulos, S. Vlachou, T. Kourouli, V. Nahmias, K. Thermos, G. Panagis, Z. Daifoti, M. Marselos, D. Papahatjis and C. Spyraki. Behavioral pharmacological properties of a novel cannabinoid 1,1-dithiolane Δ8-ΤΗC analog, AMG-3. Behavioral Pharmacology 16: 499-510, 2005.

4.      Antoniou K, Papathanasiou G, Papalexi E, Hyphantis T, Nomikos G, Spyraki C, Papadopoulou-Daifoti Z. Individual responses to novelty are associated with differences in behavioral and neurochemical profiles. Behavioural Brain Research 2008; 187(2): 462-472.

5.      Alexia Polissidis, Olga Chouliara, Andreas Galanopoulos, Marios Marselos, Zeta Papadopoulou-Daifoti, and Katerina Antoniou. Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in the conditioned place preference procedure. Life Sciences, 2009 85(5-6):248-54.

6. RentesiG, AntoniouK, MarselosM, FotopoulosA, AlboycharaliJ, KonstandiM. Long-termconsequencesofearlymaternaldeprivationinserotonergicactivityandHPAfunctioninadultrat.NeurosciLett. 2010 480(1):7-11.

7. PolissidisA, ChouliaraO, GalanopoulosA, RentesiG, DosiM, HyphantisT, MarselosM, Papadopoulou-DaifotiZ, NomikosGG, SpyrakiC, TzavaraET, AntoniouK. Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.Int J Neuropsychopharmacol. 2010 13(9):1175-91.

8. GalanopoulosA, PolissidisA, Papadopoulou-DaifotiZ, NomikosGG, AntoniouK.Δ(9)-THCandWIN55,212-2 affectbraintissuelevelsofexcitatoryaminoacidsinaphenotype-, compound-, dose-, andregion-specificmanner.BehavBrainRes. 2011 224(1):65-72.